NBCA With Dr. Timothy Fernandes About CTEPH and Other Post-Clot Complications
National Blood Clot Alliance (NBCA) posted on LinkedIn:
“November 12 is CTEPH Awareness Day. Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but serious complication that can occur after a pulmonary embolism (PE).
It happens when blood clots don’t fully dissolve, leaving behind scar-like tissue that blocks or narrows the arteries in the lungs. Over time, this can cause high blood pressure in the lungs and strain on the heart.
Common symptoms include fatigue and unexplained shortness of breath. Some people may also experience a dry cough, chest pain, or rapid heartbeat. About 1 in 25 people who have a PE could develop CTEPH.
Last year, the National Blood Clot Alliance hosted a PEP Talk with Dr. Timothy Fernandes, pulmonologist at UC San Diego Health, to discuss CTEPH and other post-clot complications.
Dr. Fernandes emphasized that CTEPH is often underdiagnosed and that listening to patients’ symptoms is key to early detection. He also urges patients to push for answers.
Watch the full discussion here.
Learn more about CTEPH and its symptoms here.”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis